Post Leonard E
POST LEONARD E, DIR, reported a transaction classified as exercise at CG Oncology, Inc. involving 1000.000000 shares for an estimated $600.00. Reported holdings after the transaction were 1000.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Jun 04, 2026
- Filing date
- Jun 05, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CGON price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-259705 Common Stock
- Transaction date
- Jun 04, 2026 Filed Jun 05, 2026, 08:30 PM · 1d delay
- Shares
- 1,000 sh $0.60 per share
- Estimated value
- $600 Computed from shares × price
- Holdings after
- 1,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026
- F2
Fully vested.
- F3
1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders…
0 other transactions
0 recent txs